Managers
CenterOak Partners’ portfolio company Service Champions has acquired ABC Cooling Heating & Plumbing (ABC), a provider of residential air conditioning and plumbing repair services headquartered in Hayward, California. ABC has provided high quality service to homeowners across the greater East Bay metropolitan area for over 65 years.
This transaction marks Service Champion’s fifth acquisition since CenterOak completed a majority investment in May 2019 and expands Service Champion’s residential service agreement base to over 45,000 across the state of California.
“We are excited to expand our footprint into the East Bay and solidify our position as the largest residential services
Evertas, a cryptoasset insurance company, has completed a USD2.8 million seed stage funding round. The funding round was led by Morgan Creek, who were joined by Plug n Play, Kailash Ventures, RenGen, Vy Capital and Wavemaker Genesis. Mark Yusko, Founder, CEO and Chief Investment Officer of Morgan Creek Capital Management & Managing Partner of Morgan Creek Digital Assets, has joined Evertas’ Board of Directors.
Evertas, which focuses on covering institutional holders of cryptoassets including exchanges, custodians, traditional financial institutions, funds, family offices and ultra-high net worth individuals, will be using these funds to support its strong growth plans.
The market capitalisation of cryptoassets is around USD270 billion and growing rapidly, but because of the highly specialised nature of underwriting the risks
Rochester Institute of Technology (RIT) has become the first US university to invest in Cosimo Ventures’s new, blockchain-focused tokenised fund, Cosimo X.
Based in Boston and Dublin, Cosimo Ventures is an investment firm focused on deep tech companies. This is the first time that any university in the US has invested directly in a tokenised venture fund.
Harvard, Yale and MIT have all made indirect investments into digital assets and blockchain tech through traditional venture funds previously, such as Andreesen Horowitz and Paradigm.
RIT is the first to directly hold a tokenised economic interest in digital security form however, according
Align Capital Partners (ACP) has made a growth capital investment in WilliamsMarston, an accounting advisory and management consulting firm with offices in Boston and New York. Co-Founders Landen Williams and Jon Marston will continue to lead the Firm through its next phase of growth.
WilliamsMarston provides public, private equity-backed and pre-IPO companies with specialised consulting services including transaction support in M&A, divestitures, initial public offerings and restructuring as well as technical accounting, interim management and process improvement. “Jon and I founded WilliamsMarston on the premise that many companies, their investors, lenders and other stakeholders were underserved in the accounting advisory space,”
IQ Capital has led a GBP 5.5 million series A funding round in CyberSmart, which helps small to medium-sized businesses combat cyber-attacks.
The fresh capital will be used to fund CyberSmart’s growth, which has seen an increase in demand with a revenue increase of 300 per cent over the past 12 months, as the lockdown accelerated the use of its cloud-based technology, according to the company.
“We are delighted to have closed our Series A funding round with GBP 5.5 million to fund our next stage of growth. Our investors have seen that we have built a great technology and
iOnctura SA, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, has raised an additional EUR5.1 million bringing its total Series A financing to EUR20.1 million. New investor 3B Future Health Fund, previously known as Helsinn Investment Fund, SICAR joins the existing blue chip investor syndicate of M Ventures, INKEF Capital, VI Partners, and Schroder Adveq, which all participated in the extension.
The funding will enable iOnctura to accelerate development of its next generation dual immune and tumour targeting therapies. Data emerging from early clinical evaluation of its lead molecule IOA-244, a highly selective
Mid-market private equity investor LDC says there are signs transaction activity had started to rebound as more companies looked beyond the impact of the pandemic to long-term growth and diversification strategies.In a half-year update, the firm announced it had backed a total of 18 investments in the first half of 2020. The majority completed since the onset of the pandemic, with momentum increasing as eight deals closed in the past four weeks alone, and its pipeline for the second half of the year building quickly.
LDC, which plans to invest GBP1.2 billion of capital over the next three years, says
Munich Private Equity Partners (MPEP) has closed its third private equity program at EUR 162 million with renowned international investors. The original target for MPEP III was EUR100 million.
MPEP launches a new private equity program approximately every 18 months. Benefiting from the relationship with its anchor investor, the mid-cap buyout specialist is able to build up substantial parts of the fund portfolios before it begins active fundraising with institutional investors. Therefore, potential investors receive favourable visibility on the manager quality and expected portfolio composition, consequently the blind pool risk typically associated with such investments is substantially reduced compared to
TrueBridge Capital Partners has closed its sixth venture capital fund-of-funds, TrueBridge Capital Partners Fund VI, with USD600 million in capital from LPs.
Investors into TrueBridge Fund VI include new and existing global LPs, including foundations and endowments, pension funds, family offices, as well as high net worth individuals.
With this latest fund, TrueBridge now manages over USD3.3 billion in assets. “Today’s global economic environment is one with a truly unprecedented level of uncertainty. Now more than ever, there is a tremendous need and opportunity to connect venture capitalists and entrepreneurs as they pioneer new technologies to better navigate our evolving
Kester Capital’s (Kester) portfolio company Frontier Medical, has sold its Infection Prevention business in a carve-out to Vernacare, backed by HIG Capital. The deal includes the brands Sharpsafe, Clinisafe and eXchange. Terms of the transaction have not been disclosed.
The exited businesses are industry-leaders in the Infection Prevention market providing an extensive range of sharps and clinical waste disposal solutions. Sharpsafe was the world’s first purpose-designed plastic sharps container. With a customer base across the UK and Europe, the business operates from its site in Blackwood, Wales.
Frontier’s core division, Frontier Therapeutics, a leading provider of differentiated Skin and
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
